2012 begins with significant momentum for Periowave Dental Technologies, Inc. We have evolved and continue our commitment to superior customer care, innovation and expansion of Periowave™ and Photodynamics worldwide. We are re-organizing for a renewed global re-launch of Periowave™. Everything we do is based on our corporate Vision, Mission and Values. I would like to share with you now the Periowave™ Vision:
• Periowave™ is the Standard of Care in every operatory
• Periowave™ changes lives by improving overall health and well being
• Periowave™ reinforces Photodynamic Therapy worldwide.
So just what has been happening at Periowave™? Here are some highlights of the past few months. Adoption of our new Hand Held Laser and Advanced Formula Treatment kits is going very well in Canada and Japan. We are working through the regulatory approval processes in other geographies to expand our global customer base of Periowave™. I am pleased to introduce Michelle Janke as the Periowave™ National Sales Director for Canada. Ms. Janke has over 15 years of sales, sales management and marketing experience in health care and pharma fields. Michelle’s mandate is to manage the sales team to fully reach the potential of Periowave™ and Photodynamics in the Canadian dental market and help instil the finest customer service in the industry. Ms. Janke’s appointment is a key element of the company’s new commercialization strategy. We have hired four Territory Managers within Canada to service our customers, grow our installed base of Periowave™ users and to increase the usage Periowave™ among our existing customer base. Please see Michelle’s previous blog post with the exciting news regarding our Canadian sales team. Leanne Carlson has been appointed Periowave™ Clinical Training Manager and will be heading the RDH training program. In addition to her practice duties and the RDH program, Leanne continues to lecture on behalf of Periowave™ and support our base of users.
Periowave™ has entered into an agreement with Mr. Aaran Wan, who is based in Hong Kong, as the Periowave™ sales representative in Asia. He is responsible for establishing the distribution channels within Asia and has signed on three new distributors for Periowave™. Wavelengths, Inc has completed its first full year as our exclusive distributor of Periowave™ in Japan. Hiro Kusumoto and team have done an exceptional job developing the Japan market for Periowave™ and have made Japan our fastest growing market. Periowave Dental Technologies, Inc is also pleased to announce it has acquired an expanded exclusive license for the disinfection and sterilization of tissues, wounds and lesions in the oral cavity from UCL Business PLC, the technology transfer company of University College London.
This expanded license includes both soft and hard tissue. As such PDTI, together with our business partner Ondine, are developing new applications for the Periowave™ Photodisinfection System including Endodontic and Peri-implantitis indications. Look for the new protocols in early 2012. 2012 will see the launch of new marketing collateral, an expanded Key Opinion Leader program, increased publications on Photodynamics and Periowave™, an improved office training program and enhanced educational events. In February, our partner Wavelengths, Inc will open the Japan Clinical Institute of Periowave™ in Tokyo, Japan. We have submitted for regulatory review in a number of other international markets and expect to receive expanded approvals in 2012. Soon you will see our new messaging, in particular SRPP – Scaling and Root Planing + Periowave™, to stress the importance of proper scaling and root planing in conjunction with Periowave™ as the new gold standard of care in the treatment of gum disease.